CONMED CORP - NOTE 2.625% 2/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q1 2024

Type / Class
Debt / NOTE 2.625% 2/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CONMED CORP - NOTE 2.625% 2/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q1 $0 $0 -$85,713,972 0
2023 Q4 $69,695,000 $85,713,972 +$334,212 122.69% 21
2023 Q3 $69,520,000 $80,788,202 -$3,985,057 115.78% 24
2023 Q2 $69,139,000 $106,417,775 +$1,346,829 153.81% 29
2023 Q1 $68,959,000 $85,367,239 +$1,376,103 122.86% 33
2022 Q4 $68,298,000 $78,332,362 +$1,471,612 113.8% 33
2022 Q3 $67,256,000 $73,852,000 -$380,484 109.68% 33
2022 Q2 $66,523,000 $80,546,268 -$405,553,464 120.91% 36
2022 Q1 $332,788,000 $572,735,916 +$12,963,630 171.96% 47
2021 Q4 $325,004,378 $541,341,922 -$18,387,278 166.57% 45
2021 Q3 $336,610,000 $522,141,694 -$9,495,370 155.06% 50
2021 Q2 $338,683,891 $547,279,189 -$4,772,264 161.6% 47
2021 Q1 $341,879,597 $536,006,954 -$6,775,007 156.56% 44
2020 Q4 $348,891,260 $489,038,837 -$8,685,744 140.0% 43
2020 Q3 $355,156,000 $399,157,964 +$5,564,261 112.11% 37
2020 Q2 $353,684,006 $372,743,603 +$10,897,819 104.71% 39
2020 Q1 $350,342,000 $327,935,681 +$327,935,681 92.91% 37